HENDERSON MICHAEL THOMAS
SEC CIK 1779990 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Dir | 68.6K | — | $7.95M | 4 | 2025-01-10 | 2026-06-22 |
Most active insiders at SYRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir | — | $399.66M |
| 2 | Turtle Cameron | CEO, Dir | — | $9.99M |
| 3 | HENDERSON MICHAEL THOMAS | Dir | — | $7.95M |
| 4 | Sloan Sheldon | Chief Medical Off | — | $7.35M |
| 5 | Burrows Scott L | CFO | — | $6.86M |
| 6 | King-Jones Heidy | See Remarks | — | $2.48M |
| 7 | Albers Jeffrey W. | Dir | — | $2.40M |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-23 21:32 | 2026-06-22 | SYRE | Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Dir | S - Sale | $100.00 | -20.0K | 68.6K | -23% | -$2.00M |
| MT | 2026-05-08 21:31 | 2026-05-08 | SYRE | Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Dir | S - Sale | $74.40 | -80.0K | 88.6K | -47% | -$5.95M |
| 2026-01-23 | 2026-01-21 | SYRE | Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Dir | J - Other | $0.00 | +63.2K | 168.6K | +60% | $0 | |
| 2025-01-14 | 2025-01-10 | SYRE | Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Dir | J - Other | $0.00 | +105.4K | 105.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations